Clinical Trials Directory

Trials / Completed

CompletedNCT04922216

Adaptive Goals and Interventions for Lifestyle Enhancement

Optimization of a mHealth Behavioral Weight Loss Intervention for Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
759 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years – 39 Years
Healthy volunteers
Not accepted

Summary

Mobile obesity interventions have the potential to reach a diverse population in need; however, while effective, have not resulted in weight losses obtained in in-person interventions. Newer digital approaches called Just-in-Time Adaptive Interventions (JITAI) that offer adaptive, personalized feedback 'when needed' and in 'real time' offer an opportunity to use digital health tools "just in time". This study seeks to identify the optimal components of a comprehensive weight loss JITAI that results in weight losses that meet or exceed those in existing remotely delivered interventions.

Detailed description

Obesity has reached epidemic proportions in the United States and is recognized as a major cause of morbidity and mortality. Young adults (18-35 years) are at particularly high risk for weight gain and obesity. In-person behavioral interventions generally produce clinically significant weight losses; however, cost and access limit their potential to reduce obesity at a population level. Although web-based interventions that mimic the structure of weekly face-to-face treatment have proven a viable alternative treatment, weight losses are generally smaller than in-person treatment. Exclusively mobile treatments have been less effective, producing 1-3 kgs over 6 months. Newer digital intervention approaches called "Just-in-Time Adaptive Interventions" (JITAIs) promise to improve upon outcomes by offering adaptive, personalized feedback on behavior "when needed" in "real time," rather than on a fixed schedule. This "just-in-time," or JIT, approach is made possible by the emergence of low-cost and widely available digital health tools that allow for the collection of continually updated health data. However, few studies have used JIT approaches in remotely delivered, fully scalable weight loss interventions. Although JITAIs are a potentially transformative approach to delivering obesity interventions, a major obstacle in their development is efficient selection of components and systematic design of an optimized intervention package that produces clinically meaningful weight losses with a population-level strategy. To solve this problem, this trial will use the Multiphase Optimization Strategy (MOST), an engineering-inspired framework, and a highly efficient experimental design to identify which levels of 5 intervention components contribute meaningfully to change in weight over 6 months among young adults with overweight and obesity. All participants (n=608) will receive a core 6-month weight loss intervention that includes evidence-based lessons, behavioral skills training, and daily weighing. With the goal of determining if greater adaptation will lead to greater weight loss, participants will be randomized to standard versus more adaptive options of 5 additional intervention components: 1) diet monitoring approach (standard vs. simplified), 2) adaptive physical activity goals (weekly vs. daily), 3) decision points for message timing (fixed vs. adaptive), 4) decision rules for message content (standard vs. adaptive), and 5) message choice (no vs. yes). Candidate components have been carefully selected from empirical evidence, tested in prior studies conducted by the research team, or in a pilot micro-randomized trial conducted by the research team. Assessments will occur at 0, 3 and 6 months to accomplish the following specific aims: 1) Build an optimized JITAI consisting of the set of intervention components that yield the greatest improvement in weight change among young adults at 6 months; 2) Conduct mediation analyses to test the relationships between the intervention components and hypothesized proximal mediators (self-regulation, competence, relatedness, relevance, autonomy) and more distal behavioral mediators (dietary intake, physical activity, and daily self-weighting); and 3) Conduct exploratory analyses of program engagement.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCoreBehavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.
BEHAVIORALStandard Diet MonitoringStandard monitoring using smartphone tracking of all calorie intake.
BEHAVIORALSimplified Diet MonitoringSimplified diet monitoring using smartphone tracking of red foods using a traffic light approach.
BEHAVIORALAdaptive Activity Goals (Daily)Physical activity goals that adapt once each day using the participants' data derived from activity tracker.
BEHAVIORALAdaptive Activity Goals (Weekly)Physical activity goals that adapt once each week using the participants' data derived from activity tracker.
BEHAVIORALMessage Decision Points (Fixed)Message timing is fixed and evaluated at specific times each day to determine message eligibility.
BEHAVIORALMessage Decision Points (Adaptive)Message timing is adaptive and derived from individual user data to determine message eligibility.
BEHAVIORALMessage Decision Rules (Standard)Decision rules to determine eligibility to receive just-in-time messages consider participant's recent behaviors.
BEHAVIORALMessage Decision Rules (Adaptive)Decision rules to determine eligibility to receive just-in-time messages consider participant's recent behaviors and overall progress.
BEHAVIORALMessage Choice (No)Participant choice does not drive adaptation of 1) message type delivered or 2) lapse support provision
BEHAVIORALMessage Choice (Yes)Participant choice drives adaptation of 1) message type delivered and 2) lapse support provision.

Timeline

Start date
2022-04-28
Primary completion
2024-06-20
Completion
2024-07-01
First posted
2021-06-10
Last updated
2025-07-20
Results posted
2025-07-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04922216. Inclusion in this directory is not an endorsement.